Cholesterol drug could boost TB treatment – new study tests best dose
NCT ID NCT07303699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the cholesterol-lowering drug atorvastatin behaves in the body when taken alongside standard tuberculosis (TB) medicines. Researchers will measure drug levels in 80 adults with pulmonary TB to find the best dose of atorvastatin that could help treat TB more effectively. The goal is to understand how these drugs interact and to build a model for future treatment optimization.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS (TB) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Federal Teaching Hospital
RECRUITINGKatsina, Katsina State, Nigeria
-
National Tuberculosis and Leprosy Training Centre, Saye
RECRUITINGZaria, Kaduna State, Nigeria
-
Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Osun state, Nigeria
RECRUITINGIle-Ife, Osun State, 2345, Nigeria